Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors...

BMC Health Services Research 2015 / 6 Vol. 15; Iss. 1

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., Postema, R., Townsend, R., Roudaut, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
BMC Health Services Research
DOI:
10.1186/s12913-015-1139-y
Date:
June, 2015
File:
PDF, 1.21 MB
english, 2015
Conversion to is in progress
Conversion to is failed